HomeCompareBVVBY vs PFE

BVVBY vs PFE: Dividend Comparison 2026

BVVBY yields 3.54% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $24.4K in total portfolio value· pulled ahead in Year 9
10 years
BVVBY
BVVBY
● Live price
3.54%
Share price
$59.98
Annual div
$2.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$444.41
Full BVVBY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BVVBY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBVVBYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BVVBY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BVVBY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVVBY
Annual income on $10K today (after 15% tax)
$300.85/yr
After 10yr DRIP, annual income (after tax)
$377.75/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,942.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVVBY + PFE for your $10,000?

BVVBY: 50%PFE: 50%
100% PFE50/50100% BVVBY
Portfolio after 10yr
$37.4K
Annual income
$13,351.57/yr
Blended yield
35.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BVVBY
No analyst data
Altman Z
4.4
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVVBY buys
0
PFE buys
0
PoliticianChamberTickerTypeAmountDate
Daniel Goldman🏢 House$BVVBY▼ Sell$1,001 - $15,0002023-07-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBVVBYPFE
Forward yield3.54%6.13%
Annual dividend / share$2.12$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$25.1K$49.6K
Annual income after 10y$444.41$26,258.71
Total dividends collected$4.0K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BVVBY vs PFE ($10,000, DRIP)

YearBVVBY PortfolioBVVBY Income/yrPFE PortfolioPFE Income/yrGap
1$11,054$353.94$9,153$693.39+$1.9KBVVBY
2$12,193$365.65$8,593$849.25+$3.6KBVVBY
3$13,424$376.95$8,336$1,066.78+$5.1KBVVBY
4$14,751$387.85$8,437$1,384.80+$6.3KBVVBY
5$16,182$398.32$9,013$1,875.40+$7.2KBVVBY
6$17,723$408.37$10,306$2,680.72+$7.4KBVVBY
7$19,382$418.00$12,820$4,101.38+$6.6KBVVBY
8$21,166$427.22$17,673$6,826.70+$3.5KBVVBY
9← crossover$23,084$436.02$27,543$12,591.86$4.5KPFE
10$25,144$444.41$49,560$26,258.71$24.4KPFE

BVVBY vs PFE: Complete Analysis 2026

BVVBYStock

Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products. The company engages in the inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its customers in relation to regulatory benchmarks or volunteers, as well as issues compliance reports. It also provides laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as designed to control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves automotive and transportation, building and infrastructure, chemicals, commodities and agriculture, consumer products and retail, food, marine and offshore, oil and gas, and power and utilities industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of 1,600 offices and laboratories. Bureau Veritas SA was founded in 1828 and is based in Neuilly-sur-Seine, France.

Full BVVBY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BVVBY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVVBY vs SCHDBVVBY vs JEPIBVVBY vs OBVVBY vs KOBVVBY vs MAINBVVBY vs JNJBVVBY vs MRKBVVBY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.